On the antiatherogenic effects of vitamin E: The search for the Holy Grail

Vascular Health and Risk Management

Volumn 6, Issue 1, 2010, Pages 69-71

  Galli, Francesco ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; POLYSULFONE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROGENESIS; BIOCOMPATIBILITY; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; DIALYSIS MEMBRANE; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; LETTER; SECONDARY PREVENTION; UREMIA;

EID: 77950834667     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/vhrm.s9289     Document Type: Letter

References (23)

1. Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet. 2000; 356:1213-1218.
2. Galli F, Buoncristiani U, Conte C, Aisa C, Floridi A. Vitamin E in uremia and dialysis patients. Ann N Y Acad Sci. 2004;1031:348-351.
3. Galli F, Floridi AG, Floridi A, Buoncristiani U. Accumulation of vitamin E metabolites in the blood of renal failure patients. Clin Nutr. 2004;23:205-212.
4. Galli F, Azzi A. BioFactors (Oxford, England). In press.
5. Galli F, Cristina Polidori M, Stahl W, Mecocci P, Kelly FJ. Vitamin E biotransformation in humans. Vitam Horm. 2007; 76:263-280.
6. Buoncristiani U, Galli F, Rovidati S, et al. Oxidative damage during hemodialysis using a vitamin-E-modified dialysis membrane: a pre- liminary characterization. Nephron. 1997;77:57-61.
7. Floridi A, Piroddi M, Pilolli F, et al. Analysis method and characteriza- tion of the antioxidant capacity of vitamin E-interactive polysulfone hemodialyzers. Acta Biomater. 2009;5:2974-2982.
8. Galli F, Canestrari F, Buoncristiani U. Biological effects of oxidant stress in haemodialysis: the possible roles of vitamin E. Blood Purif. 1999;17:79-94.
9. Galli F. Vitamin E-modified dialyzers. Contrib Nephrol. 2002;(137): 95-105.
10. Sosa MA, Balk EM, Lau J, et al. A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation. Nephrol Dial Transplant. 2006;21:2825-2833.
11. Morimoto H, Nakao K, Fukuoka K, et al. Long-term use of vita- min E-coated polysulfone membrane reduces oxidative stress mark- ers in haemodialysis patients. Nephrol Dial Transplant. 2005; 20:2775-2782.
12. Galli F, Rovidati S, Chiarantini L, et al. Bioreactivity and biocompat- ibility of a vitamin E-modified multi-layer hemodialysis filter. Kidney Int. 1998;54:580-589.
13. Clermont G, Lecour S, Cabanne JF, et al. Vitamin E-coated dialyzer reduces oxidative stress in hemodialysis patients. Free Radic Biol Med. 2001;31:233-241.
14. Galli F, Rovidati S, Benedetti S, et al. Lipid peroxidation, leukocyte function and apoptosis in hemodialysis patients treated with vitamin E-modified filters. Contrib Nephrol. 1999;127:156-171.
15. Betjes MG, Hoekstra FM, Klepper M, Postma SM, Vaessen LM. Vitamin E-coated dialyzer membranes downregulate expression of monocyte adhesion and co-stimulatory molecules. Blood Purif. 2004; 22:510-517.
16. Girndt M, Lengler S, Kaul H, Sester U, Sester M, Köhler H. Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction. Am J Kidney Dis. 2000;35:95-104.
17. Kobayashi S, Moriya H, Aso K, Ohtake T. Vitamin E-bonded hemodia- lyzer improves atherosclerosis associated with a rheological improve- ment of circulating red blood cells. Kidney Int. 2003;63:1881-1887.
18. Usberti M, Gerardi G, Bufano G, et al. Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients. Am J Kidney Dis. 2002;40: 590-599.
19. Bonnefont-Rousselot D, Lehmann E, Jaudon MC, Delattre J, Perrone B, Rechke JP. Blood oxidative stress and lipoprotein oxidizability in haemodialysis patients: effect of the use of a vitamin E-coated dialysis membrane. Nephrol Dial Transplant. 2000;15:2020-2028.
20. Bufano G, Usberti M, Mandolfo S, Malberti F, Piroddi M, Galli F. Von Willebrand factor and autoantibodies against oxidized LDL in hemodialysis patients treated with vitamin E-modified dialyzers. Int J Artif Organs. 2004;27:214-221.
21. Mune M, Yukawa S, Kishino M, et al. Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients. Kidney Int Suppl. 1999;71:S126-S129.
22. Nakamura T, Kawagoe Y, Matsuda T, et al. Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemo- dialyzed patients with arteriosclerosis obliterans. Kidney Blood Press Res. 2003;26:185-191.
23. Miyazaki H, Matsuoka H, Itabe H, et al. Hemodialysis impairs endothe- lial function via oxidative stress: effects of vitamin E-coated dialyzer. Circulation. 2000;101:1002-1006.